📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. (2018)

First Author: Holley RJ

Attributed to: The University of Manchester (UoM) bid for phase 4 of MRC Confidence in Concept (CiC) funding funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/brain/awx311

PubMed Identifier: 29186350

Publication URI: http://europepmc.org/abstract/MED/29186350

Type: Journal Article/Review

Volume: 141

Parent Publication: Brain : a journal of neurology

Issue: 1

ISSN: 0006-8950